Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96


Is Proton Therapy a "Pro" for Breast Cancer? A Comparison of Proton vs. Non-proton Radiotherapy Using the National Cancer Database.

Chowdhary M, Lee A, Gao S, Wang D, Barry PN, Diaz R, Bagadiya NR, Park HS, Yu JB, Wilson LD, Moran MS, Higgins SA, Knowlton CA, Patel KR.

Front Oncol. 2019 Jan 14;8:678. doi: 10.3389/fonc.2018.00678. eCollection 2018.


The role of postmastectomy radiotherapy in women with pathologic T3N0M0 breast cancer.

Cassidy RJ, Liu Y, Kahn ST, Jegadeesh NK, Liu X, Subhedar PD, Arciero CA, Gillespie TW, Torres MA.

Cancer. 2017 Aug 1;123(15):2829-2839. doi: 10.1002/cncr.30675. Epub 2017 Apr 7.


Proton versus intensity-modulated radiotherapy for prostate cancer: patterns of care and early toxicity.

Yu JB, Soulos PR, Herrin J, Cramer LD, Potosky AL, Roberts KB, Gross CP.

J Natl Cancer Inst. 2013 Jan 2;105(1):25-32. doi: 10.1093/jnci/djs463. Epub 2012 Dec 14.


Palliative radiotherapy for women with breast cancer.

Danielson B, Winget M, Gao Z, Murray B, Pearcey R.

Clin Oncol (R Coll Radiol). 2008 Sep;20(7):506-12. doi: 10.1016/j.clon.2008.04.013. Epub 2008 Jun 3.


Radiotherapy and Male Breast Cancer: A Population-based Registry Analysis.

Madden NA, Macdonald OK, Call JA, Schomas DA, Lee CM, Patel S.

Am J Clin Oncol. 2016 Oct;39(5):458-62. doi: 10.1097/COC.0000000000000078.


The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis.

Rusthoven CG, Rabinovitch RA, Jones BL, Koshy M, Amini A, Yeh N, Jackson MW, Fisher CM.

Ann Oncol. 2016 May;27(5):818-27. doi: 10.1093/annonc/mdw046. Epub 2016 Feb 9.


Breast cancer laterality does not influence survival in a large modern cohort: implications for radiation-related cardiac mortality.

Rutter CE, Chagpar AB, Evans SB.

Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):329-34. doi: 10.1016/j.ijrobp.2014.06.030.


Diminished survival in patients with inner versus outer quadrant breast cancers.

Gaffney DK, Tsodikov A, Wiggins CL.

J Clin Oncol. 2003 Feb 1;21(3):467-72.


Progression-free survival of children with localized ependymoma treated with intensity-modulated radiation therapy or proton-beam radiation therapy.

Sato M, Gunther JR, Mahajan A, Jo E, Paulino AC, Adesina AM, Jones JY, Ketonen LM, Su JM, Okcu MF, Khatua S, Dauser RC, Whitehead WE, Weinberg J, Chintagumpala MM.

Cancer. 2017 Jul 1;123(13):2570-2578. doi: 10.1002/cncr.30623. Epub 2017 Mar 7.


Initial Report of a Prospective Dosimetric and Clinical Feasibility Trial Demonstrates the Potential of Protons to Increase the Therapeutic Ratio in Breast Cancer Compared With Photons.

Bradley JA, Dagan R, Ho MW, Rutenberg M, Morris CG, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):411-21. doi: 10.1016/j.ijrobp.2015.09.018. Epub 2015 Sep 25.


Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base.

Jhaveri J, Cheng E, Tian S, Buchwald Z, Chowdhary M, Liu Y, Gillespie TW, Olson JJ, Diaz AZ, Voloschin A, Eaton BR, Crocker IR, McDonald MW, Curran WJ, Patel KR.

Front Oncol. 2018 Nov 28;8:440. doi: 10.3389/fonc.2018.00440. eCollection 2018.


Is regional lymph node irradiation necessary in stage II to III breast cancer patients with negative pathologic node status after neoadjuvant chemotherapy?

Daveau C, Stevens D, Brain E, Berges O, Villette S, Moisson P, Gardner M, De la Lande B, Lasry S, Labib A, Le Scodan R.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):337-42. doi: 10.1016/j.ijrobp.2009.08.053. Epub 2010 Feb 18.


Postmastectomy Radiation Therapy Is Associated With Improved Survival in Node-Positive Male Breast Cancer: A Population Analysis.

Abrams MJ, Koffer PP, Wazer DE, Hepel JT.

Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):384-391. doi: 10.1016/j.ijrobp.2017.02.007. Epub 2017 Feb 13.


A Comparison of Grade 4 Lymphopenia With Proton Versus Photon Radiation Therapy for Esophageal Cancer.

Routman DM, Garant A, Lester SC, Day CN, Harmsen WS, Sanheuza CT, Yoon HH, Neben-Wittich MA, Martenson JA, Haddock MG, Hallemeier CL, Merrell KW.

Adv Radiat Oncol. 2019 Jan 17;4(1):63-69. doi: 10.1016/j.adro.2018.09.004. eCollection 2019 Jan-Mar.


Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.

Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D.

JAMA Oncol. 2017 Jul 1;3(7):928-935. doi: 10.1001/jamaoncol.2016.6380.


Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin's lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy.

Chera BS, Rodriguez C, Morris CG, Louis D, Yeung D, Li Z, Mendenhall NP.

Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1173-80. doi: 10.1016/j.ijrobp.2008.12.048. Epub 2009 Apr 20.


Proton radiation therapy (PRT) for pediatric optic pathway gliomas: comparison with 3D planned conventional photons and a standard photon technique.

Fuss M, Hug EB, Schaefer RA, Nevinny-Stickel M, Miller DW, Slater JM, Slater JD.

Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1117-26.


Postmastectomy Radiation in Breast Cancer Patients With Pathologically Positive Lymph Nodes After Neoadjuvant Chemotherapy: Usage Rates and Survival Trends.

Ohri N, Moshier E, Ho A, Green S, Rhome R, Mazumdar M, Powell S, Tsai CJ.

Int J Radiat Oncol Biol Phys. 2017 Nov 1;99(3):549-559. doi: 10.1016/j.ijrobp.2017.06.2458. Epub 2017 Jun 28.


Factors influencing access to palliative radiotherapy: a Norwegian population-based study.

Åsli LM, Myklebust TÅ, Kvaløy SO, Jetne V, Møller B, Levernes SG, Johannesen TB.

Acta Oncol. 2018 Sep;57(9):1250-1258. doi: 10.1080/0284186X.2018.1468087. Epub 2018 Apr 28.


Supplemental Content

Support Center